Restricted accessResearch articleFirst published online 2020-10
A Virus-Like Particle-Based Solid-Phase Competition Enzyme-Linked Immunosorbent Assay for Antibody Detection of Foot-and-Mouth Disease Virus Serotype O
Foot-and-mouth disease (FMD) is caused by FMD virus (FMDV) is a highly contagious disease of ruminants, which is primarily controlled by vaccination. The monitoring of antisera after vaccination is currently depending on liquid-phase blocking ELISA (LPBE). Recently, bacterium-original FMD virus-like particle (VLP) showed the potential as vaccine candidates. In this study, to minimize the risk of live virus involvement, the Escherichia coli original VLP of FMDV serotype O were used as the immunogen for monoclonal antibodies (Mabs) production and the capture antigen in the development of a solid-phase competition ELISA (SPCE). The samples with a percentage inhibition of >50% were considered positive in the SPCE assay. The concordance rate of the Mab-based SPCE compared with the LPBE for clinical serum samples test was 93.4%, and with a high agreement (kappa = 0.892) with LPBE in antibody duration monitoring. Results indicated that the VLP-based SPCE had high specificity and sensitivity, which provides an alternative method for postimmunization antibody evaluation of FMDV serotype O.
Get full access to this article
View all access options for this article.
References
1.
OIE: Manual of Diagnostic Tests and Vaccines for Terrestrial Animals, pp. 8th Ed. World Organization for Animal Health (OIE), Paris, France, 2018.
2.
JamalSM, and BelshamGJ: Foot-and-mouth disease: Past, present and future. Vet Res, 2013; 44:116.
3.
KnowlesNJ, SamuelAR, DaviesPR, MidgleyRJ, and ValarcherJF: Pandemic strain of foot-and-mouth disease virus serotype O. Emerg Infect Dis, 2005; 11:1887–1893.
4.
ZhuZ, YangF, HeJ, LiJ, CaoW, LiJ, XiaY, GuoJ, JinY, ZhangK, ZhengH, and LiuX: First detection of foot-and-mouth disease virus O/ME-SA/Ind2001 in China. Transbound Emerg Dis, 2018; 65:2027–2031.
5.
ZhengH, HeJ, GuoJ, JinY, YangF, LvL, and LiuX: Genetic characterization of a new pandemic Southeast Asia topotype strain of serotype O foot-and-mouth disease virus isolated in China during 2010. Virus Genes, 2012; 44:80–88.
6.
RocheSE, GarnerMG, SansonRL, CookC, BirchC, BackerJA, DubeC, PatykKA, StevensonMA, YuZD, RawdonTG, and GauntlettF: Evaluating vaccination strategies to control foot-and-mouth disease: A model comparison study. Epidemiol Infect, 2015; 143:1256–1275.
7.
RoederPL, and Le Blanc SmithPM: Detection and typing of foot-and-mouth disease virus by enzyme-linked immunosorbent assay: A sensitive, rapid and reliable technique for primary diagnosis. Res Vet Sci, 1987; 43:225–232.
8.
HamblinC, BarnettIT, and HedgerRS: A new enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies against foot-and-mouth disease virus. I. Development and method of ELISA. J Immunol Methods, 1986; 93:115–121.
9.
AraujoJP, MontassierHJ, and PintoAA: Liquid-phase blocking sandwich enzyme-linked immunosorbent assay for detection of antibodies against foot-and-mouth disease virus in water buffalo sera. Am J Vet Res, 1996; 57:840–843.
10.
MackayDK, BulutAN, RendleT, DavidsonF, and FerrisNP: A solid-phase competition ELISA for measuring antibody to foot-and-mouth disease virus. J Virol Methods, 2001; 97:33–48.
11.
PaibaGA, AndersonJ, PatonDJ, SoldanAW, AlexandersenS, CorteynM, WilsdenG, HamblinP, MacKayDK, and DonaldsonAI: Validation of a foot-and-mouth disease antibody screening solid-phase competition ELISA (SPCE). J Virol Methods, 2004; 115:145–158.
12.
MaLN, ZhangJ, ChenHT, ZhouJH, DingYZ, and LiuYS: An overview on ELISA techniques for FMD. Virol J, 2011; 8:419.
13.
van MaanenC: A complex-trapping-blocking (CTB) ELISA, using monoclonal antibodies and detecting specifically antibodies directed against foot-and-mouth disease types A, O and C. I. Method and characteristics. Vet Microbiol, 1990; 24:171–178.
LiuX, FangY, ZhouP, LuY, ZhangQ, XiaoS, DongZ, PanL, LvJ, ZhangZ, ZhangY, and WangY: Chimeric virus-like particles elicit protective immunity against serotype O foot-and-mouth disease virus in guinea pigs. Appl Microbiol Biotechnol, 2017; 101:4905–4914.
16.
LiH, LiZ, XieY, QinX, QiX, SunP, BaiX, MaY, and ZhangZ: Novel chimeric foot-and-mouth disease virus-like particles harboring serotype O VP1 protect guinea pigs against challenge. Vet Microbiol, 2016; 183:92–96.
17.
DongYM, ZhangGG, HuangXJ, ChenL, and ChenHT: Promising MS2 mediated virus-like particle vaccine against foot-and-mouth disease. Antiviral Res, 2015; 117:39–43.
18.
XiaoY, ChenHY, WangY, YinB, LvC, MoX, YanH, XuanY, HuangY, PangW, LiX, YuanYA, and TianK: Large-scale production of foot-and-mouth disease virus (serotype Asia1) VLP vaccine in Escherichia coli and protection potency evaluation in cattle. BMC Biotechnol, 2016; 16:56.
19.
GuoHC, SunSQ, JinY, YangSL, WeiYQ, SunDH, YinSH, MaJW, LiuZX, GuoJH, LuoJX, YinH, LiuXT, and LiuDX: Foot-and-mouth disease virus-like particles produced by a SUMO fusion protein system in Escherichia coli induce potent protective immune responses in guinea pigs, swine and cattle. Vet Res, 2013; 44:48.
20.
ZhangY, YaoY, GaoX, WangY, JiaX, XiaoY, WangT, LiX, and TianK: Development of a neutralizing monoclonal antibody against porcine epidemic diarrhea virus S1 protein. Monoclon Antib Immunodiagn Immunother, 2016; 35:37–40.
21.
TsangVC, GreeneRM, and PilcherJB: Optimization of the covalent conjugating procedure (NaIO4) of horseradish peroxidase to antibodies for use in enzyme-linked immunosorbent assay. J Immunoassay, 1995; 16:395–418.
22.
BiswalJK, BishtP, MohapatraJK, RanjanR, SanyalA, and PattnaikB: Application of a recombinant capsid polyprotein (P1) expressed in a prokaryotic system to detect antibodies against foot-and-mouth disease virus serotype O. J Virol Methods, 2015; 215–216:45–51.
23.
RanX, YangZ, BaiM, ZhangY, WenX, GuoH, and SunS: Development and validation of a competitive ELISA based on bacterium-original virus-like particles of serotype O foot-and-mouth disease virus for detecting serum antibodies. Appl Microbiol Biotechnol, 2019; 103:3015–3024.
24.
YangY, ZhaoQ, LiZ, SunL, MaG, ZhangS, and SuZ: Stabilization study of inactivated foot and mouth disease virus vaccine by size-exclusion HPLC and differential scanning calorimetry. Vaccine, 2017; 35:2413–2419.
25.
SpittelerMA, RomoA, MagiN, SeoMG, YunSJ, BarroumeresF, RegulierEG, and BellinzoniR: Validation of a high performance liquid chromatography method for quantitation of foot-and-mouth disease virus antigen in vaccines and vaccine manufacturing. Vaccine, 2019; 37:5288–5296.
26.
FengX, MaJW, SunSQ, GuoHC, YangYM, JinY, ZhouGQ, HeJJ, GuoJH, QiSY, LinM, CaiH, and LiuXT: Quantitative detection of the foot-and-mouth disease virus serotype O 146S antigen for vaccine production using a double-antibody sandwich ELISA and nonlinear standard curves. PLoS One, 2016; 11:e0149569.
